These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22727507)

  • 1. Flow cytometry to distinguish myelodysplastic syndromes from non-neoplastic causes of cytopenia: ready for prime time?
    Hasserjian RP; Preffer FI
    Leuk Res; 2012 Sep; 36(9):1089-90. PubMed ID: 22727507
    [No Abstract]   [Full Text] [Related]  

  • 2. Multi-color CD34⁺ progenitor-focused flow cytometric assay in evaluation of myelodysplastic syndromes in patients with post cancer therapy cytopenia.
    Tang G; Jorgensen LJ; Zhou Y; Hu Y; Kersh M; Garcia-Manero G; Medeiros LJ; Wang SA
    Leuk Res; 2012 Aug; 36(8):974-81. PubMed ID: 22626984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pancytopenia after viral infection in St. n. malignant lymphoma].
    Seifert B; Favre G
    Praxis (Bern 1994); 2003 Jan; 92(4):143-6. PubMed ID: 12632845
    [No Abstract]   [Full Text] [Related]  

  • 4. Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood.
    Aalbers AM; van den Heuvel-Eibrink MM; de Haas V; Te Marvelde JG; de Jong AX; van der Burg M; Dworzak M; Hasle H; Locatelli F; De Moerloose B; Schmugge M; Stary J; Zecca M; Zwaan CM; van de Loosdrecht AA; van Dongen JJ; Niemeyer CM; van der Velden VH
    Leukemia; 2013 Sep; 27(9):1923-5. PubMed ID: 23493026
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias.
    Cremers EMP; Westers TM; Alhan C; Cali C; Wondergem MJ; Poddighe PJ; Ossenkoppele GJ; van de Loosdrecht AA
    Eur J Cancer; 2016 Feb; 54():49-56. PubMed ID: 26720403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometry in myelodysplastic syndromes: ready for translation into clinical practice.
    van de Loosdrecht AA; Westers TM
    Leuk Res; 2011 Jul; 35(7):850-2. PubMed ID: 21529940
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosis of myelodysplastic syndromes in cytopenic patients.
    Wang SA
    Hematol Oncol Clin North Am; 2011 Oct; 25(5):1085-110, vii. PubMed ID: 22054736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of flow cytometry for myelodysplastic syndromes: Pitfalls and technical considerations.
    Alhan C; Westers TM; Cremers EM; Cali C; Ossenkoppele GJ; van de Loosdrecht AA
    Cytometry B Clin Cytom; 2016 Jul; 90(4):358-67. PubMed ID: 26517178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary myelodysplastic syndromes].
    Brohée D
    Rev Med Brux; 1988 Sep; 9(6):327-33. PubMed ID: 3051250
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood.
    Aalbers AM; van den Heuvel-Eibrink MM; Baumann I; Dworzak M; Hasle H; Locatelli F; De Moerloose B; Schmugge M; Mejstrikova E; Nováková M; Zecca M; Zwaan CM; Te Marvelde JG; Langerak AW; van Dongen JJ; Pieters R; Niemeyer CM; van der Velden VH
    Haematologica; 2015 Mar; 100(3):315-23. PubMed ID: 25425683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometry in myelodysplastic syndrome: analysis of diagnostic utility using maturation pattern-based and quantitative approaches.
    Chopra A; Pati H; Mahapatra M; Mishra P; Seth T; Kumar S; Singh S; Pandey S; Kumar R
    Ann Hematol; 2012 Sep; 91(9):1351-62. PubMed ID: 22526362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometry in myelodysplastic syndromes: report from a working conference.
    Loken MR; van de Loosdrecht A; Ogata K; Orfao A; Wells DA
    Leuk Res; 2008 Jan; 32(1):5-17. PubMed ID: 17576013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is There a Role for Flow Cytometry in the Evaluation of Patients With Myelodysplastic Syndromes?
    Porwit A
    Curr Hematol Malig Rep; 2015 Sep; 10(3):309-17. PubMed ID: 26122389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometry will be a routine tool in clinical practice in myelodysplastic syndromes: a real story.
    Ogata K
    Leuk Res; 2011 Jul; 35(7):848-9. PubMed ID: 21466893
    [No Abstract]   [Full Text] [Related]  

  • 15. [Myelodysplastic syndromes and autoimmunity].
    Stalder G; Alberio L; Ribi C
    Rev Med Suisse; 2015 Apr; 11(469):820-2, 824-5. PubMed ID: 26040163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparameter flow cytometric analysis reveals low percentage of bone marrow hematogones in myelodysplastic syndromes.
    Maftoun-Banankhah S; Maleki A; Karandikar NJ; Arbini AA; Fuda FS; Wang HY; Chen W
    Am J Clin Pathol; 2008 Feb; 129(2):300-8. PubMed ID: 18208811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelodysplasia.
    Heaney ML; Golde DW
    N Engl J Med; 1999 May; 340(21):1649-60. PubMed ID: 10341278
    [No Abstract]   [Full Text] [Related]  

  • 18. Flow cytometry immunophenotyping in integrated diagnostics of patients with newly diagnosed cytopenia: one tube 10-color 14-antibody screening panel and 3-tube extensive panel for detection of MDS-related features.
    Porwit A; Rajab A
    Int J Lab Hematol; 2015 May; 37 Suppl 1():133-43. PubMed ID: 25976971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myelodysplastic syndromes].
    Raza A; Vadhan-Raj S; Chávez-Sánchez G
    Rev Invest Clin; 1997 May; 49 Suppl 1():15-21. PubMed ID: 9380984
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of myelodysplastic syndromes: just the beginning.
    Kim H; Garcia-Manero G
    Oncology (Williston Park); 2008 Nov; 22(12):1360, 1363, 1368. PubMed ID: 19320068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.